focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biodyn Regulatory News (OBD)

Share Price Information for Oxford Biodyn (OBD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.80
Bid: 7.50
Ask: 7.98
Change: -0.04 (-0.51%)
Spread: 0.48 (6.40%)
Open: 8.40
High: 8.40
Low: 7.70
Prev. Close: 7.84
OBD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

8 Dec 2016 09:29

RNS Number : 3211R
Oxford BioDynamics PLC
08 December 2016
 
 
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

OXFORD BIODYNAMICS PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

ALEXANDRE AKOULITCHEV

 

4. Full name of shareholder(s)  (if different from 3.):iv

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

06 DEC 2016

6. Date on which issuer notified:

07 DEC 2016

7. Threshold(s) that is/are crossed orreached: vi, vii

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

GB00BD5H8572

6,452,145

6,452,145

5,806,930

5,806,930

6.7%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

5,806,930

6.7%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will cease to hold:

12. Date on which proxy holder will cease to hold voting rights:

13. Additional information:

14. Contact name:

Alexandre Akoulitchev (CSO)

Oxford BioDynamics Plc

15. Contact telephone number:

+44 (0) 1865 518 910

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLEANAPEASKFEF
Date   Source Headline
27th May 20219:00 amRNSNotice of Results
14th May 202110:17 amRNSPDMR Dealing / Grant of Share Options
28th Apr 20212:24 pmRNSHolding(s) in Company
9th Apr 20217:00 amRNSNew UK facilities to support expanded strategy
31st Mar 20217:00 amRNSOBD signs agreement with Agilent Technologies
24th Mar 202112:46 pmRNSResult of AGM
23rd Mar 20217:00 amRNSUS launch of EpiSwitch® COVID-19 Severity Test
17th Mar 20219:53 amRNSResults published of biomarker discovery program
23rd Feb 20211:36 pmRNSPublication of 2020 Annual Report and AGM date
28th Jan 20217:00 amRNSFinal Results
12th Jan 20217:00 amRNSNotice of Results
30th Dec 20207:00 amRNSDirectorate Change
15th Dec 20207:00 amRNSOxford BioDynamics to expand strategic focus
14th Dec 20207:00 amRNSAppointment of Chairman
2nd Nov 20207:00 amRNSStrategic partnership with Boca Biolistics
28th Oct 20207:00 amRNSDisease severity program for COVID-19 advances
8th Jul 20207:00 amRNSPDMR Dealing / Grant of Share Options
30th Jun 20201:04 pmRNSPDMR Dealing
23rd Jun 20202:09 pmRNSPDMR Dealing
17th Jun 20207:00 amRNSPDMR Dealing
16th Jun 20207:00 amRNSInterim results for six months ended 31 March 2020
3rd Jun 20201:30 pmRNSBoard transition
21st May 20207:00 amRNSBusiness update and notice of interim results
15th May 202012:47 pmRNSPDMR Dealing
14th May 202012:39 pmRNSPDMR Dealing
1st May 20207:00 amRNSChange of Registered Office
30th Apr 20207:00 amRNSBiomarker platform COVID-19 update
22nd Apr 20201:12 pmRNSPDMR Dealing
20th Apr 202011:10 amRNSPDMR Dealing
17th Apr 202010:47 amRNSPDMR Dealing
16th Apr 20204:35 pmRNSPrice Monitoring Extension
15th Apr 20203:10 pmRNSPDMR Dealing
14th Apr 202011:42 amRNSPDMR Dealing
8th Apr 20204:34 pmRNSPDMR Dealing
2nd Apr 202011:08 amRNSPDMR Dealing - Replacement
31st Mar 20207:00 amRNSPDMR Dealing / Grant of Share Options
23rd Mar 20203:21 pmRNSPDMR Dealing
20th Mar 20203:02 pmRNSPDMR Shareholding
20th Mar 20201:37 pmRNSResults of Annual General Meeting
20th Mar 20207:30 amRNSDirector Dealing
19th Mar 20207:00 amRNSDirector Dealing
18th Mar 20207:00 amRNSPDMR Dealing
16th Mar 20207:00 amRNSBoard restructure to support future growth
2nd Mar 20205:04 pmRNSPDMR Dealing
2nd Mar 20205:03 pmRNSCorrection - PDMR Dealing
2nd Mar 20205:02 pmRNSCorrection - PDMR Dealing
28th Feb 20202:08 pmRNSPDMR Dealing
26th Feb 202011:49 amRNSPDMR Dealing
20th Feb 20207:00 amRNSOBD to present at BioTech Pharma Summit
20th Feb 20207:00 amRNSOBD to present at BioTech Pharma Summit

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.